News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
María José Juan-Fita: It’s probably time to open the field of tumour microenvironment research and test new therapies in prostate cancer as well
Photo of María José Juan-Fita taken from: educa-med.online/educa-news
Mar 7, 2024, 01:32

María José Juan-Fita: It’s probably time to open the field of tumour microenvironment research and test new therapies in prostate cancer as well

María José Juan-Fita, Medical Oncologist at the Valencian Institute of Oncology Foundation, shared the following post by Emmanuel Antonarakis, Professor of Medicine, University of Minnesota, on X, adding the following:

“It’s probably time to open the field of tumour microenvironment research and test new therapies in prostate cancer as well.”

María José Juan-Fita: It’s probably time to open the field of tumour microenvironment research and test new therapies in prostate cancer as well María José Juan-Fita: It’s probably time to open the field of tumour microenvironment research and test new therapies in prostate cancer as well María José Juan-Fita: It’s probably time to open the field of tumour microenvironment research and test new therapies in prostate cancer as well María José Juan-Fita: It’s probably time to open the field of tumour microenvironment research and test new therapies in prostate cancer as well

“Congrats Nicholas Zorko for your new paper characterizing NK cell landscape in PCa, and the associated clinical and molecular features. Now it’s time for some NK-directed therapeutics in PCa. Thanks to PCF Science for funding this brilliant young investigator.”

Source: María José Juan-Fita/X and Emmanuel Antonarakis/X

cancer María José Juan-Fita Nicholas Zorko NK cell OncoDaily Oncology PCF Science Research
Special Coverage
Blog
May 9, 2025, 10:15
Sarah Sammons Comments on TDXd Use in Early HER2+ Breast Cancer
Blog
May 9, 2025, 10:04
Aakash Desai: AI in Predicting EGFR Mutations from Whole Slide Images in Lung Cancer
Blog
May 9, 2025, 09:39
Yakup Ergün: One of the Key Upcoming Presentations at ESMO Breast 2025
Blog
May 9, 2025, 09:37
Erika Hamilton: PROTAC Data at ASCO25 in the MBC Oral Session
Blog
May 9, 2025, 09:29
ESO - M2ICOS Project Launches Fellowship Program to Support Oncology Training and Mobility in the EU
Science
May 9, 2025, 09:22
Myeloma Paper of the Day, May 9th, suggested by Robert Orlowski
Drugs
May 9, 2025, 09:15
Penpulimab: Uses in Cancer, Side Effects, Dosage, Expectations, and More
Drugs
May 9, 2025, 08:47
Jonathan Pachter: FDA Grants Accelerated Approval for 1st Targeted Therapy in KRAS-Mutant LGSOC
Blog
May 9, 2025, 08:15
Parminder Singh: Grand Rounds at Mayo Clinic
Science
May 9, 2025, 08:02
Ashish Kamat: Predictive Value of AI Histologic Biomarker CHAI in NMIBC Treatment
Drugs
May 9, 2025, 07:54
Rahul Banerjee: Financial Toxicity Is the First Side Effect of Lenalidomide in Multiple Myeloma
Blog
May 9, 2025, 07:41
Eric Singhi: First-Year Fellow’s Graduation from the Singhi Clinic